A quick look at yesterday: a tough session dominated by bearish sentiment left Fresenius Medical Care 26 cents lower, while setting a $17.64 to $17.91 session range.
Initial Jobless Claims data from United States will be released today at 13:30 UTC with analysts expecting a decline to 205,000. Potentially significant price fluctuations in Fresenius Medical Care are expected to follow.
United States Crude Oil Inventories fell short of the 971,000 projections, with new data of 533,000.
Meanwhile, United States 5-Year Note Auction released yesterday at 18:00 UTC with a figure of 3.53, while the previous figure was 3.973. United States Cushing Crude Oil Inventories released yesterday at 15:30 UTC with a figure of 4.27 million, while the previous figure was 3.65 million.
Technical analysis of Fresenius Medical Care's past price action reveals multiple support and resistance levels: Fresenius Medical Care AG & Co. KGaA bounced after reaching the $17.66 support zone, climbing 12 cents above it.
Fresenius Medical Care was not the only decliner in the health care sector; Abbott Laboratories went down 1.36%, closed at $112.53.
On the other hand, positive performances could be seen by looking at other health care stocks as Bristol-Myers Squibb Company was up 1.15%. Pfizer traded at $45.07 after closing yesterday's trading day at $44.71 (up 0.81%).
Looking ahead, ongoing depreciation may be prolonged as as things stand, upcoming United States Core Durable Goods Orders data is projected to fall short of market expectations with newly published data of -0.2%, following on from the preceding figure of 0.1%. New data is set to be published today at 13:30 UTC.
Moreover, United States Pending Home Sales is projected to outperform its last figure with -0.9%, having previously been at -4%. The figure will be published tomorrow at 15:00 UTC.
Furthermore, United States Core PCE Price Index (MoM) (Dec) scheduled to come out tomorrow at 13:30 UTC.
The stock has been trending positively for about a month. The kidney dialysis specialist has managed to gain 12% so far this year despite trading at lows around $12.81 previously.